These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25633325)

  • 1. Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
    Schinnerling K; Soto L; García-González P; Catalán D; Aguillón JC
    Autoimmun Rev; 2015 Jun; 14(6):517-27. PubMed ID: 25633325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
    Harry RA; Anderson AE; Isaacs JD; Hilkens CM
    Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific CD4
    Jansen MAA; Spiering R; Ludwig IS; van Eden W; Hilkens CMU; Broere F
    Front Immunol; 2019; 10():2068. PubMed ID: 31555285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
    Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S
    Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?
    Jansen MAA; Spiering R; Broere F; van Laar JM; Isaacs JD; van Eden W; Hilkens CMU
    Immunology; 2018 Jan; 153(1):51-59. PubMed ID: 28804903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
    Raϊch-Regué D; Grau-López L; Naranjo-Gómez M; Ramo-Tello C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE
    Eur J Immunol; 2012 Mar; 42(3):771-82. PubMed ID: 22488365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis.
    Ning B; Wei J; Zhang A; Gong W; Fu J; Jia T; Yang SY
    PLoS One; 2015; 10(6):e0131152. PubMed ID: 26107250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoints and the regulation of tolerogenicity in dendritic cells: Implications for autoimmunity and immunotherapy.
    Funes SC; Manrique de Lara A; Altamirano-Lagos MJ; Mackern-Oberti JP; Escobar-Vera J; Kalergis AM
    Autoimmun Rev; 2019 Apr; 18(4):359-368. PubMed ID: 30738957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis.
    Stoppelenburg AJ; Schreibelt G; Koeneman B; Welsing P; Breman EJ; Lammers L; de Goede A; Duiveman-de Boer T; van Eden W; Leufkens P; de Vries IJM; Broere F; van Laar JM
    BMJ Open; 2024 Sep; 14(9):e078231. PubMed ID: 39266308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis.
    Spiering R; Jansen MAA; Wood MJ; Fath AA; Eltherington O; Anderson AE; Pratt AG; van Eden W; Isaacs JD; Broere F; Hilkens CMU
    J Transl Med; 2019 Nov; 17(1):375. PubMed ID: 31727095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
    Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
    J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell vaccination in autoimmune disease.
    Gross CC; Wiendl H
    Curr Opin Rheumatol; 2013 Mar; 25(2):268-74. PubMed ID: 23370378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases.
    García-González P; Ubilla-Olguín G; Catalán D; Schinnerling K; Aguillón JC
    Autoimmun Rev; 2016 Nov; 15(11):1071-1080. PubMed ID: 27485011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells, T cells and their interaction in rheumatoid arthritis.
    Wehr P; Purvis H; Law SC; Thomas R
    Clin Exp Immunol; 2019 Apr; 196(1):12-27. PubMed ID: 30589082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?
    Stoop JN; Robinson JH; Hilkens CM
    Ann Rheum Dis; 2011 Sep; 70(9):1526-33. PubMed ID: 21804099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.
    Kim SH; Jung HH; Lee CK
    Yonsei Med J; 2018 Sep; 59(7):807-815. PubMed ID: 30091313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent discoveries in dendritic cell tolerance-inducing pharmacological molecules.
    Švajger U; Rožman PJ
    Int Immunopharmacol; 2020 Apr; 81():106275. PubMed ID: 32044665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.
    Obreque J; Vega F; Torres A; Cuitino L; Mackern-Oberti JP; Viviani P; Kalergis A; Llanos C
    Immunology; 2017 Dec; 152(4):648-659. PubMed ID: 28763099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Functional Characterization of Murine Tolerogenic Dendritic Cells.
    Wei HJ; Letterio JJ; Pareek TK
    J Vis Exp; 2018 May; (135):. PubMed ID: 29863666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
    Mackern-Oberti JP; Llanos C; Vega F; Salazar-Onfray F; Riedel CA; Bueno SM; Kalergis AM
    Autoimmun Rev; 2015 Feb; 14(2):127-39. PubMed ID: 25449681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.